There’s already reason to be suspicious of conflicts of interest with TrumpRx, the senators note. There’s a “potential relationship between TrumpRx and an online dispensing company, BlinkRx, on whose Board the President’s son, Donald Trump, Jr., has sat since February 2025,” the senators write.